Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Resch Martin H.President & CEO | Tax withholding | F | $43K 894 sh | Apr 22, 2026 |
| 9 | Faga DanielDirector, President, CEO | Grant or award | A | — 69.4K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Otitoju Kolawole A.Chief Bus. & Strategy Officer | Grant or award | A | — 146.8K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 9 | Ware J. AnthonyDirector | Grant or award | A | — 9,200 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Ware J. AnthonyDirector | Grant or award | A | — 6,000 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Faga DanielDirector, President, CEO | Grant or award | A | — 17.9K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Lizzul Paul F.Chief Medical Officer | Grant or award | A | — 21.4K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Nutz PeterEVP/ Chief Credit Officer | Tax withholding | F | $2,683 143 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Cox Erin NealyDirector | Option exercise | M | — 15.5K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 9 | Marquet MagdaDirector | Grant or award | A | — 10.6K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Humes JenniferChief Accounting Officer | Grant or award | A | — 27.2K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | You Harry L.Director | Grant or award | A | — 864 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Krawiec PeterDirector | Grant or award | A | — 897 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Ware J. AnthonyDirector | Grant or award | A | — 11.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Whiteside JaneyDirector | Grant or award | A | — 928 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Ware J. AnthonyDirector | Grant or award | A | — 16.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Ware J. AnthonyDirector | Grant or award | A | — 16.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Faga DanielDirector, President, CEO | Grant or award | A | — 11.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Faga DanielDirector, President, CEO | Grant or award | A | — 2,321 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Resch Martin H.President & CEO | Tax withholding | F | $40K 830 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | McCormick Andrew J.Gen. Counsel & Corp. Secretary | Tax withholding | F | $2,172 2,227 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 9 | Pulik RichardCFO | Grant or award | A | — 84.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Low Check KianDirector | Grant or award | A | — 864 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Faga DanielDirector, President, CEO | Grant or award | A | — 194.9K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Cox Erin NealyDirector | Option exercise | M | — 12.5K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 9 | Lizzul Paul F.Chief Medical Officer | Grant or award | A | — 21.1K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Prahm JeremyChief Investment Officer | Open-market sale · 10b5-1 plan | SELL | $138K 6,000 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Ware J. AnthonyDirector | Grant or award | A | — 4,000 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Ware J. AnthonyDirector | Grant or award | A | — 5,500 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Marquet MagdaDirector | Grant or award | A | — 11.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Lizzul Paul F.Chief Medical Officer | Grant or award | A | — 45.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Jain RitaDirector | Grant or award | A | — 16.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Hutchins Glenn HDirector | Grant or award | A | $7,829 67 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Lizzul Paul F.Chief Medical Officer | Grant or award | A | — 67.1K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Lizzul Paul F.Chief Medical Officer | Grant or award | A | — 115.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Marquet MagdaDirector | Grant or award | A | — 784 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Lizzul Paul F.Chief Medical Officer | Grant or award | A | — 29.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Lizzul Paul F.Chief Medical Officer | Grant or award | A | — 97.2K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Frey Anthony GeorgeSVP and Chief Revenue Officer | Tax withholding | F | $14K 532 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Venker EricPresident & Immunovant CEO | Option exercise · 10b5-1 plan | M | $770K 200.0K sh | Apr 22, 2026 traded Apr 20, 2026 |